L1000-Phase2 (Project)

Id Namespace:

Library of Integrated Network-Based Cellular Signatures

Identifier Namespace (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Persistent Id:https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE70138

Description:The Library of Integrated Cellular Signatures (LINCS) is an NIH program which funds the generation of perturbational profiles across multiple cell and perturbation types, as well as read-outs, at a massive scale. The LINCS Center for Transcriptomics at the Broad Institute uses the L1000 high-throughput gene-expression assay to build a Connectivity Map which seeks to enable the discovery of functional connections between drugs, genes and diseases through analysis of patterns induced by common gene-expression changes.

Abbreviation:CMAP2

Results found

Linked to

	Label	Description
	LINCS Project (Entity type)	The Library of Integrated Network-Based Cellular Signatures (LINCS) Program aims to create a network...
	L1000 LINCS DCIC XPR002 HELA.311 96H I15 AKT2 2.00uL Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC REP.A014 YAPC 24H H15 ubenimex 1.11um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC REP.A008 MCF7 24H K11 MG-132 20.00um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC REP.A004 HT29 24H L02 solifenacin-succinate 3.33um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC REP.A016 HT29 24H N06 dexamethasone 0.04um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC REP.A006 YAPC 24H P15 warfarin 1.11um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC REP.A027 A375 24H K06 cladribine 0.04um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC REP.A002 PC3 24H N06 lenalidomide 0.04um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC REP.A028 YAPC 24H M10 itopride 0.37um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project

LINCS

Project (Entity type)

The Library of Integrated Network-Based Cellular Signatures (LINCS) Program aims to create a network...

L1000 LINCS DCIC XPR002 HELA.311 96H I15 AKT2 2.00uL

Biosample (Entity type)